Emcure Pharma Q3 Results: Net profit jumps 30% on-year, margin shrinks

Investors reacted positively to the results, with Emcure Pharmaceuticals Ltd shares rising 3.6% on Thursday to close at ₹1,294.80 on the BSE. 

Leave a Reply

Your email address will not be published. Required fields are marked *